FDA Inspection 1151483 — Biomat USA, Inc.
The FDA completed an inspection of Biomat USA, Inc. on August 6, 2021 in Boise, ID. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 6, 2021
- Fiscal Year
- 2021
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Boise, ID (United States)